Daiwa Securities Group Inc. - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 148 filers reported holding PDL BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q2 2020$2,0000.0%6440.0%0.00%
Q1 2020$2,0000.0%6440.0%0.00%
Q4 2019$2,0000.0%644
-24.5%
0.00%
Q3 2019$2,000
-33.3%
8530.0%0.00%
Q2 2019$3,0000.0%8530.0%0.00%
Q1 2019$3,000
+50.0%
8530.0%0.00%
Q4 2018$2,0000.0%8530.0%0.00%
Q3 2018$2,0000.0%8530.0%0.00%
Q2 2018$2,000
-33.3%
8530.0%0.00%
Q1 2018$3,000
-98.9%
853
-97.1%
0.00%
-100.0%
Q2 2014$283,000
-83.4%
29,644
-85.5%
0.00%
-84.6%
Q1 2014$1,701,000204,7190.01%
Other shareholders
PDL BIOPHARMA INC shareholders Q2 2019
NameSharesValueWeighting ↓
HAYS ADVISORY LLC 1,037,600$6,672,0000.97%
Global X Management CO LLC 2,435,411$15,660,0000.86%
Advisors Asset Management, Inc. 5,373,113$34,549,0000.47%
Gotham Asset Management, LLC 7,233,838$46,514,0000.39%
TFS CAPITAL LLC 582,438$3,745,0000.37%
LOMBARDIA CAPITAL PARTNERS LLC 1,637,611$10,530,0000.36%
AMERICAFIRST CAPITAL MANAGEMENT, LLC 95,122$611,634,0000.33%
FIRST TRUST ADVISORS LP 17,536,793$112,762,0000.29%
Arrow Investment Advisors, LLC 214,595$1,380,0000.28%
GSA CAPITAL PARTNERS LLP 954,853$6,140,0000.24%
View complete list of PDL BIOPHARMA INC shareholders